Delivery Order SPE2DB25D3017-SPE2DB25FVJNA
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,978.56 and a completion date of May 14, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a ceiling value of $7,222.61. The contract has a firm fixed price pricing type and a performance period ending on June 10, 2025. The contract is not set aside for any particular business type. AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 10 MG CAPSULE 100S, a medication, with a ceiling value of $2,922.41 and a completion date of May 15, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger...
- This is a $1,543.45 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 30 MG CAPSULE 100S, a prescription medication, with a period of performance through June 5, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a medication, with a ceiling value of $2,674.50 and a completion date of May 13, 2025. The contract is a firm fixed-price delivery order and is not set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a prescription medication, with a ceiling value of $3,542.56 and an ultimate completion date of July 2, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of VYVANSE 60 MG CAPSULE 100S, a neurological medication, with a ceiling value of $1,940.54 and a period of performance through July 10, 2025. The contract is not designated as a set-aside and represents an open competition. Amerisourcebergen Drug Corporation holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,772.23 and a period of performance through July 9, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open...
- This is a $1,189.34 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYVANSE 30 MG CAPSULE 100S, a prescription medication, with a performance period extending through June 10, 2025. This delivery order is not set aside and represents open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a $15,212.33 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a medication, with a period of performance ending on March 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVJNADelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a ceiling value of $1,410.48 and a period of performance ending on June 23, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for the agency, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 6/20/25 |